| BANBBachem Holding | CHF792.00 | 1.8% | 109.8% | CHF11.1b | CHF616.00 | P/E112.7x | E19.7% | 0.4% | |
| PPGNPolyPeptide Group | CHF130.80 | 4.0% | n/a | CHF4.3b | CHF144.41 | P/E82.8x | E14.5% | n/a | |
| SFZNSiegfried Holding | CHF850.00 | 0.9% | 48.3% | CHF3.6b | CHF955.88 | P/E51.1x | E16.3% | 0.4% | |
| ADXNAddex Therapeutics | CHF1.50 | 0.7% | -22.7% | CHF51.2m | CHF25.72 | P/S12.8x | E-24.7% | n/a | |
| NWRNNewron Pharmaceuticals | CHF2.07 | 0.2% | 8.7% | CHF36.9m | CHF7.83 | P/S6.3x | E59.3% | n/a | |
| WBIOWockhardt Bio | CHF0.85 | 0% | -66.0% | CHF44.2m | n/a | P/E1.3x | n/a | 0% | |
| POLNPolyphor | CHF1.96 | -2.0% | -72.8% | CHF23.1m | n/a | P/S1.6x | E61.1% | n/a | |
| KURNKuros Biosciences | CHF2.46 | -1.2% | -1.6% | CHF80.7m | n/a | P/S20x | n/a | n/a | |
| SANNSanthera Pharmaceuticals Holding | CHF1.40 | -36.4% | -76.7% | CHF55.0m | CHF6.40 | P/S3.7x | E54.4% | n/a | |
| SKINCassiopea | CHF34.80 | -3.1% | -29.8% | CHF374.1m | CHF56.77 | P/S581.3x | E29.1% | n/a | |
| COPNCosmo Pharmaceuticals | CHF80.90 | -1.9% | -3.6% | CHF1.2b | CHF104.77 | P/S16.9x | E58.6% | 0% | |
| MOLNMolecular Partners | CHF18.00 | -4.2% | 16.4% | CHF581.0m | CHF27.57 | P/S93x | E17.7% | n/a | |
| TECNTecan Group | CHF576.00 | -0.3% | 28.7% | CHF7.3b | CHF605.00 | P/E48.6x | E10.3% | 0.4% | |
| BSLNBasilea Pharmaceutica | CHF44.78 | -7.1% | -5.4% | CHF528.4m | CHF87.60 | P/S4.7x | E67.5% | 0% | |
| VIFNVifor Pharma | CHF120.50 | -0.6% | -4.5% | CHF7.8b | CHF142.44 | P/E36.6x | E20.8% | 1.7% | |
| IDIAIdorsia | CHF22.26 | -1.9% | -11.1% | CHF3.7b | CHF31.13 | P/S135.8x | E31.3% | n/a | |
| RLFRelief Therapeutics Holding | CHF0.13 | -12.2% | -75.7% | CHF568.9m | n/a | P/S645x | S54.8% | n/a | |
| LONNLonza Group | CHF742.60 | -1.4% | 30.6% | CHF55.2b | CHF765.21 | P/E100.3x | E20.2% | 0.4% | |
| NOVNNovartis | CHF76.96 | -0.6% | -4.2% | CHF172.1b | CHF94.55 | P/E20.7x | E7.4% | 3.8% | |
| ROGRoche Holding | CHF340.40 | -0.7% | 2.9% | CHF297.6b | CHF382.65 | P/E20.7x | E6.4% | 2.7% | |